18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
NCT06414902
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
ArabinoFuranosylGuanine [18F]F-AraG
Sponsor
M.D. Anderson Cancer Center